A-Z
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
- 0-9
Classification
Publication

- Full text
- Title
- Author
- ISBN/ISSN
- Publisher
AdvancedSearch
- AdvancedSearch
- Search help

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT₃receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States

Author： Schwartzberg Lee Morrow Gary Balu Sanjeev Craver Chris Gayle Julie Cox David

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.8, 2011-08, pp. : 1613-1622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aprepitant as Salvage Therapy in Patients with Chemotherapy-Induced Nausea and Emesis Refractory to Prophylaxis with 5-HT₃ Antagonists and Dexamethasone

By

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 557-561

Access to resources Recommend Favorite

QoL evaluation of olanzapine for chemotherapy‐induced nausea and vomiting comparing with 5‐HT3 receptor antagonist

By

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 3, 2015-05 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemotherapy-Induced Emesis in Elderly Cancer Patients: The Role of 5-HT₃-Receptor Antagonists in the First 24 Hours

By

Gerontology, Vol. 51, Iss. 5, 2005-08 ,pp. : 287-296

Access to resources Recommend Favorite

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite